Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium for Succinylcholine-Induced Myofibrillation
NCT05909696Completed
- Sponsor
- Yangzhou University
- Start
- Jul 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of rocuronium (3 arms), sponsored by Yangzhou University. Primary endpoint: Appearance of myofibrillation. Started Jul 2023; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on NCT05909696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909696.